Drug name：

Peritoneal dialysis solution(lactate)

Specifications：

concentration：1.5%、2.5% 、4.25% ；

specifications：1000ml，1500ml，2000ml，2500ml，3000ml

Components：

This product is a compound formulation, containing 15g (or 25g, 42.5g) of glucose, 5.38g of sodium chloride, 0.26g of calcium chloride, 0.051g of magnesium chloride, and 4.48g of sodium lactate per 1000ml.

Indications：

This product is suitable for chronic renal failure patients who require continuous ambulatory peritoneal dialysis (CAPD) treatment due to ineffective non dialysis treatment.

Acute renal failure: If there are no contraindications, peritoneal dialysis can be chosen

Chronic renal failure: peritoneal dialysis is feasible without absolute contraindications

Priority should be given to peritoneal dialysis in the following situations
1. Infants and children;
2. Poor vascular conditions or repeated arteriovenous fistula failure;
3. Coagulation dysfunction with obvious bleeding or bleeding tendency;
4. The residual kidney function is good;
5. Those who prefer home treatment or need to work or attend school during the day;
6. Patients in rural areas and remote areas far from central cities

toxic diseases

For patients with acute drug and toxin poisoning, especially those with contraindications to hemodialysis or those who undergo hemodialysis unconditionally, peritoneal dialysis can be used for treatment

others
1. Adjuvant treatment for liver diseases such as congestive heart failure,
2. acute pancreatitis,
3. hepatic encephalopathy, and hyperbilirubinemia;
4. Intraperitoneal administration and nutritional support